Advances in Rehabilitation
facebook
twitter
ISSN: 1734-4948
Advances in Rehabilitation
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2025
vol. 39
 
Share:
Share:
Review article

Improving gait and daily function in stroke survivors: a systematic review on the effects of Transcutaneous Electrical Nerve Stimulation

Maria Fernanda Serna Orozco
1
,
Jose Ricardo Rojas-López
2
,
Florencio Arias-Coronel
3
,
Harold Andrés Payán-Salcedo
4

  1. Research Group Biomateriales y Biotecnología (BEO), Universidad Santiago de Cali, Cali, Colombia
  2. Faculty of Health, Universidad Santiago de Cali, Cali, Colombia
  3. Grupo de Investigación en Salud Integral (GISI), Universidad Santiago de Cali, Cali, Colombia
  4. Research Group Salud y Movimiento, Universidad Santiago de Cali, Cali, Colombia
Adv Rehab. 2025. 39(2): 15-28
Online publish date: 2025/04/02
Article file
- Orozco_2025_04_09.pdf  [0.36 MB]
Get citation
 
PlumX metrics:
 

INTRODUCTION

Stroke is one of the leading causes of disability and the second leading cause of mortality worldwide. It is estimated that one in four individuals will experience a stroke, with approximately 15 million new cases occurring annually¹˒². In Colombia, stroke ranks among the top five causes of mortality, with a reported rate of 32 deaths per 100,000 inhabitants³. In the city of Cali, approximately 3,101 stroke cases are registered each year, of which around 2,636 are ischemic strokes⁴.
Stroke is a neurological disorder characterized by the obstruction of cerebral blood vessels due to a blood clot, leading to reduced cerebral blood flow and subsequent brain damage⁵. The clinical manifestations of stroke vary depending on the location and severity of the lesion, with hemiplegia being one of the most common motor sequelae⁶.
Hemiplegia is characterized by muscle paralysis on one side of the body and may be accompanied by other symptoms, such as sensory, cognitive, and language impairments⁷. One of the most common sequelae is motor involvement, resulting in functional limitations that affect gait pattern. These gait alterations hinder mobility and performance in activities of daily living⁸˒⁹. The rehabilitation of hemiplegia aims to restore motor function and improve independence through various therapeutic strategies. Among these, transcutaneous electrical stimulation (TENS)¹⁰ has shown promising effects in reducing spasticity, enhancing muscle strength, and managing pain associated with musculoskeletal disorders¹¹.
TENS is a peripheral electrical stimulation technique that delivers low- and high-frequency (50–150 Hz) electrical currents through the skin¹². Although traditionally used for pain relief¹³, studies suggest that TENS may also influence muscle strength and spasticity in patients with neurological conditions¹⁴˒¹⁵. These effects are believed to result from the activation of afferent fibers of different diameters¹⁶, hemodynamic changes during electrically-induced muscle contractions¹⁷, reduced stretch reflex excitability, and presynaptic inhibition¹⁸.
TENS is a noninvasive, cost-effective therapy that can be applied using portable devices; as such, it is an accessible option for both clinical and home-based rehabilitation¹⁹. However, while existing studies indicate that TENS can improve muscle strength, reduce spasticity, and enhance motor function in hemiplegic patients, its optimal dosage, duration, and effects on gait remain unclear. Despite the existence of previous literature reviews on the use of TENS in post-stroke patients, critical gaps remain that necessitate further investigation. Many prior reviews have primarily examined the effects of TENS on motor recovery, pain management, or spasticity reduction, often without a specific emphasis on functional mobility and gait rehabilitation. Additionally, inconsistencies in methodology and stimulation parameters, and a lack of standardized outcome measures in previous reviews limit the ability to draw definitive conclusions about the efficacy of TENS in improving gait. Given these uncertainties, this systematic review aims to analyze the effects of TENS on gait and daily function in stroke survivors, providing insights into its potential role in post-stroke rehabilitation.

MATERIALS AND METHODS

This study was conducted following the Cochrane Collaboration recommendations and the PRISMA statement. The protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO), under number CRD42023488243.
Eligibility criteria
This review included experimental, quasi-experimental, cohort, case-control, and cross-sectional studies. All involved patients with hemiplegia, and evaluated TENS application protocols and gait performance through various parameters, including speed, distance, cadence, step amplitude, and specific gait analyzers. The secondary outcome examined activities of daily living. The exclusion criteria encompassed studies involving children and adolescents, patients with cranioencephalic trauma or neurodegenerative diseases, electrotherapy protocols using currents other than TENS, studies that did not assess gait as a primary outcome, narrative reviews, case studies, letters to the editor, and expert opinions, studies with insufficient methodological quality or incomplete data reporting and animal studies or research conducted on in vitro models.
Data sources
The following databases were used: MEDLINE (OVID), ScienceDirect, LILACS, WEB OF SCIENCE, and the Cochrane Central Register of Controlled Trials (CENTRAL). Controlled clinical trials, case-control, cohort, and cross-sectional studies were included from inception to November 2023. To ensure full coverage of the literature, the search also included relevant papers identified through the references, as well as congresses, thesis databases, Open Grey, Google Scholar, and Clinicaltrials.gov. The search was performed using DeCS/Mesh terms and related words with different combinations of Boolean operators. No language or time restrictions were imposed (Appendix 1).
Data collection
Data were extracted by two investigators. Both reviewed each paper based on the title and abstract. Following this, the full texts of the relevant studies were read, based on the inclusion and exclusion criteria mentioned above, and further data were obtained. Disagreements were resolved by consensus; when there was no agreement, a third reviewer participated.
Using a standardized form, two trained reviewers independently extracted the following information from each article: study design, location, authors’ names, title, purposes, number of patients included, time, outcome definitions, results, and association measures.
Risk of bias (quality) assessment
The quality and risk of bias of nonrandomized studies were assessed using the methodological index for nonrandomized studies (MINORS) score²⁰ in an independent and blinded manner, including studies with a score higher than 11. Clinical trials, were assessed using the PEDro scale²¹, which evaluates randomization and blinding, and result processing. Studies with a score of 6–10 were considered to have high methodological quality, and these were included. Discrepancies between authors during the quality assessment were resolved by discussion; if no agreement was reached, a third author was consulted.

RESULTS

Study Selection and Eligibility Criteria
A total of 2,785 studies were initially identified through the database search. After removing duplicates, 531 studies remained for title and abstract screening. At this stage, 465 studies were excluded for being systematic reviews, letters to the editor, intervention protocols, or unrelated to the topic of interest.
The remaining 66 studies underwent full-text review, where 59 were excluded for not meeting the inclusion criteria. The final selection process included an assessment of methodological quality using the PEDro scale, which led to the exclusion of one study due to a low rating. Ultimately, five²²,²⁶ controlled clinical trials met all eligibility criteria and were included in this review (Figure 1).
The included studies were conducted in Asia, with two from Hong Kong²²˒²³, two from Korea²⁴˒²⁶, one from Seoul²⁵. All were published in English (Table 1).
Methodological quality
As shown in Table S1, the mean PEDro scale score for the included studies was 8. The most frequent omissions were observed in concealed allocation and blinding of therapists when administering therapy.
Characteristics of participants
Table 2 presents the characteristics of participants. Age ranged from 52 to 71 years, all studies included populations of both sexes²²,²⁶ and included samples from 29²⁵ to 109 participants²³. The side affected by hemiplegia was reported in two studies²²˒²³, with the left hemisphere being the most frequent. Poststroke time was given in months and years, and specified in three studies²²˒²⁵˒²⁶, ranging from one month to six years.
TENS Application Protocols
All studies used the same application protocol for TENS ²²־²⁶, with parameters set at 100 Hz and 200 μs pulse width, applied at twice the sensory threshold intensity. Treatment duration varied, with three studies²⁴־²⁶ using 30-minute sessions and two studies²²˒²³ applying 60-minute sessions. Electrode placement also varied among studies: two studies²⁴˒²⁶ targeted the common peroneal nerve pathway, two ²²˒²³ placed electrodes on Chinese acupuncture points (ST 36, LV 3, GB 34, UB 60), and one ²⁵ positioned electrodes over the muscle belly of the quadriceps and gastrocnemius (medial and lateral areas) (Table 2).
Effects on Gait Parameters
Lower Limb Spasticity: Four studies²²˒²⁴־²⁶ assessed spasticity reduction, with all reporting significant improvements in gait parameters. All studies used a five-day-per-week intervention schedule with an average duration of six weeks. Three of these studies implemented 30-minute TENS sessions targeting the common peroneal nerve pathway²⁴־²⁶ and one study used 60-minute sessions with Chinese acupuncture point placements²². All studies demonstrated a significant reduction in spasticity and improvements in gait speed and muscle strength (dorsiflexors and plantar flexors) in patients receiving TENS compared to placebo groups (Table 3).
Gait Speed: Five studies²²־²⁶ evaluated gait speed, with four²²־²⁵ combining TENS with task-related exercises. These studies reported significant improvements in gait speed for patients receiving TENS + exercise compared to those receiving TENS alone or placebo, with the TENS + exercise group sustaining long-term improvements (Table 4).
Muscle Strength and Functional Mobility: Three studies²²˒²⁴˒²⁶ assessed plantar flexor and dorsiflexor muscle strength using a load cell on a standing frame²² and a handheld dynamometer²⁴˒²⁶. Two studies²⁴˒²⁶ applied 30-minute TENS sessions targeting the common peroneal nerve pathway. One²² used a 60-minute protocol with acupuncture-based electrode placement. Significant improvements in muscle strength were observed in patients receiving TENS + exercise/task-based interventions compared to those receiving TENS alone or placebo (Table 5).
Other Gait-Related Variables and Functional Performance: Beyond gait speed and muscle strength, other variables such as balance, endurance, and functional mobility were assessed (Table 6).
Balance: One study²⁵ used the Good Balance device and timed up-and-go test, showing significant improvements in static and dynamic balance when TENS was applied to the quadriceps and gastrocnemius.
Endurance and Functional Gait Mobility: One study²³ used the 6-minute walk test, finding greater improvement in TENS + exercise groups compared to the control group, with sustained effects over time. Additionally, the study found significant improvements in TENS-treated patients, but greater and longer-lasting benefits were observed in those who received TENS + exercise interventions.

DISCUSSION

The findings of our systematic review show that the combination of TENS with therapeutic exercises positively affects gait and performance in daily living in patients with hemiplegia secondary to stroke; it appears to do so by relieving spasticity and improving inter alia speed, functionality, and gait endurance.
Application of TENS for four to six weeks, five times a week, decreases spasticity in patients with hemiplegia; should be applied as a 100 Hz current with a pulse width of 200 μ, at twice the sensory threshold, over the common peroneal nerve pathway.
In patients with hemiplegia, common peroneal nerve dysfunction is commonly associated with gait abnormalities resulting in foot drop²⁷; electrical stimulation has been shown to improve ankle dorsiflexion, balance, and functional mobility in this population²⁸, even in functional task-related training. In 2019, Mahmood et al.²⁹ reported that TENS reduced limb spasticity when administered in combination with other forms of physical therapy for more than 30 minutes. This is consistent with the results reported by Laddha et al., who concluded that the use of TENS for 30 or 60 minutes can effectively reduce spasticity in the ankle plantar flexors, thereby increasing gait ability and enhancing the effectiveness of task-related training³⁰. Shorter application times do not seem to be effective for treating spasticity: Picelli et al. do not note any significant differences between 15-minute TENS application to the tibial nerve and the use of ultrasound on the gastrocnemius in patients with spastic clubfoot ³¹.
Decreased strength in the periarticular muscles of the ankle contributes to alterations in gait pattern, and reduced speed and alterations in the stance and swing phases, which are controlled by the plantar and dorsiflexor. The studies included in this review reported that the combination of task-related exercises and the application of TENS to the common peroneal nerve motor point significantly improved muscle strength of the dorsiflexors and plantar flexors compared to the use of TENS alone. This finding is consistent with those of Yan et al., who reported that the use of TENS administered five times a week within 10 days after stroke significantly reduced plantar flexor spasticity and increased ankle dorsiflexor strength³².
Moreover, these parameters were effective for other gait-related variables, such as gait speed and gait endurance, when current was applied to the hemiplegic side. However, a greater long-term effect was observed in protocols in which the current was applied together with task-related exercises. In these patients, the use of TENS appears to be particularly useful as adjunctive therapy in a task-related training program for the improvement of motor skills³³.
In addition to strength and gait speed, an essential component for walking is balance. Kyoung-Sim Jung et al. proposed that the use of TENS significantly helps the dynamic balance of patients with stroke sequelae when performing functional movements such as standing up and sitting down from a chair ³⁴. This is consistent with the results obtained in one of the analyses considered in this review, where a significant improvement in the ability to stand up without loss of balance was reported following four-week application of TENS current to acupuncture points of the paretic leg.
The use of therapeutic currents to improve performance and independence in activities of daily living has also been reported in other studies, such as that of Liu, et al., where they demonstrated that the use of TENS for 30 min with frequencies of 20 Hz had positive effects in poststroke patients, and improved urinary incontinence and performance in activities of daily living assessed with the Barthel index³⁵. In this review, a significant improvement above the mean Barthel index score was observed, especially in the items of bladder control, feeding, transfers, and mobility.
Strengths and limitations
This review highlights the therapeutic potential of TENS in improving gait and daily function, and provides valuable insights regarding evidence-based clinical practice and rehabilitation strategies for stroke survivors. Unlike previous reviews that primarily focused on motor recovery or pain management, this study emphasizes the functional effects of TENS in this population. It also employs a rigorous methodology, including a structured search strategy, clearly-defined inclusion and exclusion criteria, and quality assessment using the PEDro scale, ensuring the reliability of the selected studies.
However, this review is potentially limited by the small number of studies evaluating the effects of TENS on gait parameters. Additionally, the variability in outcome measures used to assess gait and daily function makes it challenging to draw definitive conclusions and establish standardized recommendations for clinical practice.
Implications for Further Research
Future research should focus on standardizing TENS application protocols by defining optimal stimulation parameters, treatment duration, and electrode placements to enhance its clinical effectiveness. Additionally, larger, high-quality randomized controlled trials with long-term follow-up are needed to assess the sustained effects of TENS on gait and daily function in stroke survivors.

CONCLUSIONS

The use of TENS in the treatment of patients with stroke sequelae is a useful strategy to optimize activities of daily living and gait. However, a careful and detailed evaluation of each patient is required, taking into account contextual factors, individual conditions, and clinical characteristics.
The analysis of the results showed a positive improvement in variables related to gait and activities of daily living. Nevertheless, despite the positive results, some of the limitations of this review are related to the variability in the application times of the protocols and the variability in sample sizes and characteristics of the participants included. Therefore, further research should be conducted to provide more understanding of the long-term effects of TENS and to establish an effective application protocol for rehabilitation programs.

FUNDING

This research has been funded by the Dirección General de Investigaciones de Universidad Santiago de Cali under call No. 01-2025.

CONFLICTS OF INTEREST

The authors declare no conflict of interest.
REFERENCES
1. World Health Organization. World Stroke Day 2022. 2022. [Consulted 15 Oct 2024]. Available in: https://www.who.int/srilanka/news/detail/29-10-2022-world-stroke-day-2022.
2. Purroy F, Montalà N. Epidemiología del ictus en la última década: revisión sistemática. Rev Neurol. 2021; 73(09): 321. doi:10.33588/rn.7309.2021138.
3. Guerrero Agámez D, Pestaña Utria G, Diaz Arrieta B, Vargas Moranth R, Alvis Guzmán N. Mortalidad por enfermedades cerebrovasculares en Colombia: 30 años de observación. Acta Neurol Colomb. 2021;37(4): 173–88. doi:10.22379/24224022386.
4. Secretaria de Salud Pública de Santiago de Cali. Red de atención especial contra el ataque cerebrovascular (ACV) para el distrito especial de Santiago de Cali. 2020. [Consulted 15 Oct 2024]. Available in:https://www.cali.gov.co/loader.php?lServicio=Tools2&lTipo=descargas&lFuncion=descargar&idFile=60214.
5. Burgaya Subirana S, Macià Rieradevall E, Cabral Salvadores M, Ramos Calvo AM. Ictus: un reto diagnóstico. Rev Pediatr Aten Primaria. 2021; 23(90): 179–82.
6. Diener HC, Wachter R. Diagnose und Therapie des akuten ischämischen Insults. Herz. 2021;46(2): 195–204. doi:10.1007/s00059-021-05021-6.
7. dos Santos de Souza G, Rossato CE, Mota CB, Silveira AF. Assessment of motor function in individuals with hemiplegia post-stroke. Fisioter Pesqui. 2023; 30: e22008723pt. doi:10.1590/1809-2950/e22008723en.
8. Sun X, Xu K, Shi Y, Li H, Li R, Yang S, et al. Discussion on the rehabilitation of stroke hemiplegia based on interdisciplinary combination of medicine and engineering. Evid Based Complement Alternat Med. 2021; 2021: 1–11. doi:10.1155/2021/6631835.
9. Li S, Francisco GE, Zhou P. Post-stroke hemiplegic gait: New perspective and insights. Front. Physiol. 2018; 9: 1021. doi:0.3389/fphys.2018.01021.
10. Rhyu HS, Rhi SY. The effects of training on different surfaces, on balance and gait performance in stroke hemiplegia. Rev Bras Med Esporte. 2021; 27(6): 592–6. doi:0.1590/1517-8692202127062020_0089.
11. Chasiotis A, Giannopapas V, Papadopoulou M, Chondrogianni M, Stasinopoulos D, Giannopoulos S, Bakalidou D. The effect of neuromuscular electrical nerve stimulation in the management of post-stroke spasticity: A scoping review. Cureus. 2022; 14(11): e32001. doi:10.7759/cureus.32001.
12. Fernández-Tenorio E, Serrano-Muñoz D, Avendaño-Coy J, Gómez-Soriano J. Estimulación eléctrica nerviosa transcutánea como tratamiento de la espasticidad: una revisión sistemática. Neurología. 2019; 34(7): 451–60. doi:10.1016/j.nrl.2016.06.009.
13. Johnson M. Transcutaneous electrical nerve stimulation: Mechanisms, Clinical application and evidence. Rev Pain. 2009; 1(1): 7–11. doi:10.1177/204946370700100103.
14. Mahmood A, Veluswamy SK, Hombali A, Mullick A, Manikandan N, Solomon JM. Effect of transcutaneous electrical nerve stimulation on spasticity in adults with stroke: A systematic review and meta-analysis. Arch Phys Med Rehab. 2019; 100(4): 751–68. doi:10.1016/j.apmr.2018.10.016.
15. In TS, Jung JH, Jung KS, Cho HY. Effectiveness of transcutaneous electrical nerve stimulation with taping for stroke rehabilitation. Biomed Res Int. 2021; 2021: 1–7. doi:10.1155/2021/9912094.
16. Underwood FB, Kremser GL, Finstuen K, Greathouse DG. Increasing involuntary torque production by using TENS. J Orthop Sports Phys Ther. 1990; 12(3): 101–4. doi:10.2519/jospt.1990.12.3.101.
17. Miller BF, Gruben KG, Morgan BJ. Circulatory responses to voluntary and electrically induced muscle contractions in humans. Phys Ther. 2020; 80(1): 53–60. doi:10.1093/ptj/80.1.53.
18. Okuma Y, Lee RG. Reciprocal inhibition in hemiplegia: Correlation with clinical features and recovery. Can. J. Neurol. Sci. 2015; 23(1): 15–23. doi:10.1017/s0317167100039135.
19. Shankaranarayana AM, Gururaj S, Natarajan M, Balasubramanian CK, Solomon JM. Gait training interventions for patients with stroke in India: A systematic review. Gait Posture. 2021; 83: 132–40. doi:10.1016/j.gaitpost.2020.10.012.
20. Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non‐randomized studies (MINORS): development and validation of a new instrument. ANZ J. Surg. 2003; 73(9): 712–6. doi:10.1046/j.1445-2197.2003.02748.x.
21. Maher CG, Sherrington C, Herbert RD, Moseley AM, Elkins M. Reliability of the PEDro scale for rating quality of randomized controlled trials. Phys Ther. 2003; 83(8): 713–21. doi:10.1093/ptj/83.8.713.
22. Ng SSM, Hui-Chan CWY. Transcutaneous electrical nerve stimulation combined with task-related training improves lower limb functions in subjects with chronic stroke. Stroke. 2007; 38(11): 2953–9. doi:10.1161/strokeaha.107.490318.
23. Ng SSM, Hui-Chan CWY. Does the use of TENS increase the effectiveness of exercise for improving walking after stroke? A randomized controlled clinical trial. Clin Rehabil. 2009; 23(12): 1093–103. doi:10.1177/0269215509342327.
24. In TS, Jung JH, Jung KS, Cho HY. Effectiveness of transcutaneous electrical nerve stimulation with taping for stroke rehabilitation. Biomed Res Int. 2021; 2021: 1–7. doi:10.1155/2021/9912094.
25. Junhyuck P, Dongkwon S, Wonjae Ch, Seungwon L. The effects of exercise with TENS on spasticity, balance, and gait in patients with chronic stroke: A randomized controlled trial. Med Sci Monit. 2014; 20: 1890–96. doi:10.12659/msm.890926.
26. Jung KS, Jung JH, In TS, Cho HY. Effectiveness of heel-raise-lower exercise after transcutaneous electrical nerve stimulation in patients with stroke: A randomized controlled study. J. Clin. Med. 2020; 9(11): 3532. doi:10.3390/jcm9113532.
27. Mao YR, Zhao JL, Bian MJ, Lo WLA, Leng Y, Bian RH, et al. Spatiotemporal, kinematic and kinetic assessment of the effects of a foot drop stimulator for home-based rehabilitation of patients with chronic stroke: a randomized clinical trial. J Neuroeng Rehabil. 2022; 19(1):56. doi:10.1186/s12984-022-01036-0.
28. da Cunha MJ, Rech KD, Salazar AP, Pagnussat AS. Functional electrical stimulation of the peroneal nerve improves post-stroke gait speed when combined with physiotherapy. A systematic review and meta-analysis. Ann Phys Rehabil Med. 2021; 64(1): 101388. doi:10.1016/j.rehab.2020.03.012.
29. Mahmood A, Veluswamy SK, Hombali A, Mullick A, Manikandan, Solomon JM. Effect of transcutaneous electrical nerve stimulation on spasticity in adults with stroke: A systematic review and meta-analysis. Arch Phys Med Rehabil. 2019; 100(4): 751–68. doi:10.1016/j.apmr.2018.10.016.
30. Laddha D, Ganesh GS, Pattnaik M, Mohanty P, Mishra C. Effect of transcutaneous electrical nerve stimulation on plantar flexor muscle spasticity and walking speed in stroke patients: TENS and spasticity. Physiother Res Int. 2016; 21(4): 247–56. doi:10.1002/pri.1638.
31. Picelli A, Dambruoso F, Bronzato M, Barausse M, Gandolfi M, Smania N. Efficacy of therapeutic ultrasound and transcutaneous electrical nerve stimulation compared with botulinum toxin type A in the treatment of spastic equinus in adults with chronic stroke: A pilot randomized controlled trial. Top Stroke Rehabil. 2014; 21(sup1): S8–S16. doi:10.1310/tsr21s1-s8.
32. Yan T, Hui-Chan CWY. Transcutaneous electrical stimulation on acupuncture points improves muscle function in subjects after acute stroke: A randomized controlled trial. J Rehabil Med. 2009; 41(5): 312–16. doi:10.2340/16501977-0325.
33. Hui-Chan CWY, Ng SSM, Mak MKY. Effectiveness of a home-based rehabilitation programme on lower limb functions after stroke. Hong Kong Med J. 2009; 15(3 Suppl 4): 42–6.
34. Jung KS, In TS, Cho HY. Effects of sit-to-stand training combined with transcutaneous electrical stimulation on spasticity, muscle strength and balance ability in patients with stroke: A randomized controlled study. Gait Posture. 2017; 54: 183–7. doi:10.1016/j.gaitpost.2017.03.007.
35. Liu Y, Xu G, Luo M, Teng HF. Effects of transcutaneous electrical nerve stimulation at two frequencies on urinary incontinence in poststroke patients: A randomized controlled trial. Am J Phys Med Rehabil. 2016; 95(3): 183–93. doi:10.1097/phm.0000000000000360.
This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.










Quick links
© 2025 Termedia Sp. z o.o.
Developed by Bentus.